Annual Long Term Debt
$517.00 K
-$382.00 K-42.49%
31 December 2023
Summary:
Y-mAbs Therapeutics annual long term debt is currently $517.00 thousand, with the most recent change of -$382.00 thousand (-42.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.50 million (-74.32%). YMAB annual long term debt is now -74.32% below its all-time high of $2.01 million, reached on 31 December 2020.YMAB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$299.00 K
-$133.00 K-30.79%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly long term debt is currently $299.00 thousand, with the most recent change of -$133.00 thousand (-30.79%) on 30 September 2024. Over the past year, it has dropped by -$426.00 thousand (-58.76%). YMAB quarterly long term debt is now -88.12% below its all-time high of $2.52 million, reached on 30 September 2020.YMAB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.5% | -58.8% |
| 3 y3 years | -74.3% | -54.3% |
| 5 y5 years | +100.0% | -83.6% |
YMAB Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.3% | at low | -83.8% | +2.0% |
| 5 y | 5 years | -74.3% | -88.1% | +2.0% | |
| alltime | all time | -74.3% | -88.1% |
Y-mAbs Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $299.00 K(-30.8%) |
| June 2024 | - | $432.00 K(+47.4%) |
| Mar 2024 | - | $293.00 K(-43.3%) |
| Dec 2023 | $517.00 K(-42.5%) | $517.00 K(-28.7%) |
| Sept 2023 | - | $725.00 K(+74.3%) |
| June 2023 | - | $416.00 K(-33.9%) |
| Mar 2023 | - | $629.00 K(-30.0%) |
| Dec 2022 | $899.00 K(-51.4%) | $899.00 K(-11.8%) |
| Sept 2022 | - | $1.02 M(-21.7%) |
| June 2022 | - | $1.30 M(-18.5%) |
| Mar 2022 | - | $1.60 M(-13.7%) |
| Dec 2021 | $1.85 M | $1.85 M(+183.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $654.00 K(-33.8%) |
| June 2021 | - | $988.00 K(-34.8%) |
| Mar 2021 | - | $1.51 M(-24.7%) |
| Dec 2020 | $2.01 M(+17.4%) | $2.01 M(-20.0%) |
| Sept 2020 | - | $2.52 M(+79.9%) |
| June 2020 | - | $1.40 M(-9.3%) |
| Mar 2020 | - | $1.54 M(-10.0%) |
| Dec 2019 | $1.71 M(>+9900.0%) | $1.71 M(-5.9%) |
| Sept 2019 | - | $1.82 M(-8.0%) |
| June 2019 | - | $1.98 M(-7.2%) |
| Mar 2019 | - | $2.13 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Y-mAbs Therapeutics annual long term debt?
- What is the all time high annual long term debt for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual long term debt year-on-year change?
- What is Y-mAbs Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly long term debt year-on-year change?
What is Y-mAbs Therapeutics annual long term debt?
The current annual long term debt of YMAB is $517.00 K
What is the all time high annual long term debt for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual long term debt is $2.01 M
What is Y-mAbs Therapeutics annual long term debt year-on-year change?
Over the past year, YMAB annual long term debt has changed by -$382.00 K (-42.49%)
What is Y-mAbs Therapeutics quarterly long term debt?
The current quarterly long term debt of YMAB is $299.00 K
What is the all time high quarterly long term debt for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly long term debt is $2.52 M
What is Y-mAbs Therapeutics quarterly long term debt year-on-year change?
Over the past year, YMAB quarterly long term debt has changed by -$426.00 K (-58.76%)